Skip to main content
. 2020 Mar 11;82(4):467–474. doi: 10.1292/jvms.19-0450

Fig. 2.

Fig. 2.

Weekly body weight measurements to evaluate the hypoglycemic effect of treatment with dapagliflozin (0.1 mg/kg) alone, insulin (3–5 U/rat) alone, or a combination of dapagliflozin (0.1 mg/kg) and insulin (1.5–2.5 U/rat) for the 8-week study. The values are expressed as the mean ± standard deviation. *P<0.05 versus the control group.